tiprankstipranks
Advertisement
Advertisement

HK:2410 Stock Latest News

TYK Medicines Extends Deadline for Major H-Share Subscription Deal
Company AnnouncementsTYK Medicines Extends Deadline for Major H-Share Subscription Deal
7d ago
2410
TYK Medicines Clarifies Board Structure and Committee Roles
PremiumCompany Announcements
TYK Medicines Clarifies Board Structure and Committee Roles
10d ago
2410
TYK Medicines Narrows Interim Loss as Other Income Surges Despite Higher R&D Spend
PremiumCompany Announcements
TYK Medicines Narrows Interim Loss as Other Income Surges Despite Higher R&D Spend
10d ago
2410
TYK Medicines reshapes board roles and plans director re-election
PremiumCompany Announcements
TYK Medicines reshapes board roles and plans director re-election
10d ago
2410
TYK Medicines Schedules Board Meeting to Approve Interim Results and Consider Dividend
PremiumCompany Announcements
TYK Medicines Schedules Board Meeting to Approve Interim Results and Consider Dividend
22d ago
2410
TYK Medicines Launches Legal Challenge Over TY-9591 Agreements
PremiumCompany AnnouncementsTYK Medicines Launches Legal Challenge Over TY-9591 Agreements
1M ago
2410
TYK Medicines Strikes Major TY-9591 Deal With Qilu and Raises RMB400m via H Share Placement
Premium
Company Announcements
TYK Medicines Strikes Major TY-9591 Deal With Qilu and Raises RMB400m via H Share Placement
1M ago
2410
TYK Medicines Wins Shareholder Approval for New Share Issue Mandate
Premium
Company Announcements
TYK Medicines Wins Shareholder Approval for New Share Issue Mandate
1M ago
2410
TYK Medicines calls July EGM to seek mandate for new share issuance
PremiumCompany Announcements
TYK Medicines calls July EGM to seek mandate for new share issuance
2M ago
2410
TYK Medicines Sets Share Register Closure Ahead of Extraordinary General Meeting
PremiumCompany Announcements
TYK Medicines Sets Share Register Closure Ahead of Extraordinary General Meeting
2M ago
2410
TYK Medicines shareholders back key AGM resolutions but reject share issue mandate
PremiumCompany Announcements
TYK Medicines shareholders back key AGM resolutions but reject share issue mandate
2M ago
2410
TYK Medicines’ Asandeutertinib Shows Superior Brain Metastasis Control in Phase II Lung Cancer Trial
PremiumCompany Announcements
TYK Medicines’ Asandeutertinib Shows Superior Brain Metastasis Control in Phase II Lung Cancer Trial
3M ago
2410
TYK Medicines Sets 2025 AGM to Vote on Results, Capital Mandates and Governance Changes
PremiumCompany AnnouncementsTYK Medicines Sets 2025 AGM to Vote on Results, Capital Mandates and Governance Changes
3M ago
2410
TYK Medicines Narrows Annual Loss as R&D Spending Holds Steady and Governance Changes Loom
Premium
Company Announcements
TYK Medicines Narrows Annual Loss as R&D Spending Holds Steady and Governance Changes Loom
5M ago
2410
TYK Medicines to Present Five Novel Cancer Drug Programs at 2026 AACR Meeting
Premium
Company Announcements
TYK Medicines to Present Five Novel Cancer Drug Programs at 2026 AACR Meeting
5M ago
2410
TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity
PremiumCompany Announcements
TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity
6M ago
2410
TYK Medicines Dilutes Stake in TYK Bio via RMB83.5 Million Capital Injection
PremiumCompany Announcements
TYK Medicines Dilutes Stake in TYK Bio via RMB83.5 Million Capital Injection
6M ago
2410
TYK Medicines Wins Approval for Full H-Share Circulation in Hong Kong
PremiumCompany Announcements
TYK Medicines Wins Approval for Full H-Share Circulation in Hong Kong
7M ago
2410
TYK Medicines’ Lung Cancer Drug Asandeutertinib NDA Accepted by China’s NMPA
PremiumCompany Announcements
TYK Medicines’ Lung Cancer Drug Asandeutertinib NDA Accepted by China’s NMPA
7M ago
2410
TYK Medicines’ Lung Cancer Drug Asandeutertinib Granted Priority Review in China
PremiumCompany AnnouncementsTYK Medicines’ Lung Cancer Drug Asandeutertinib Granted Priority Review in China
7M ago
2410
TYK Medicines Wins CSRC Nod for Conversion of 4.6 Million Unlisted Shares into H Shares
Premium
Company Announcements
TYK Medicines Wins CSRC Nod for Conversion of 4.6 Million Unlisted Shares into H Shares
7M ago
2410
TYK Medicines Secures Zhejiang Drug Manufacturing License to Support Cancer Drug Commercialisation
Premium
Company Announcements
TYK Medicines Secures Zhejiang Drug Manufacturing License to Support Cancer Drug Commercialisation
7M ago
2410

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >